Sysmex (TSE:6869) FCF Margin % : 8.62% (As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Sysmex FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Sysmex's Free Cash Flow for the three months ended in Mar. 2024 was 円11,632 Mil. Sysmex's Revenue for the three months ended in Mar. 2024 was 円134,985 Mil. Therefore, Sysmex's FCF Margin % for the quarter that ended in Mar. 2024 was 8.62%.

As of today, Sysmex's current FCF Yield % is 0.84%.

The historical rank and industry rank for Sysmex's FCF Margin % or its related term are showing as below:

TSE:6869' s FCF Margin % Range Over the Past 10 Years
Min: 2.97 Med: 7.57 Max: 10.19
Current: 2.97

During the past 13 years, the highest FCF Margin % of Sysmex was 10.19%. The lowest was 2.97%. And the median was 7.57%.

TSE:6869's FCF Margin % is ranked better than
66.1% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: -7.29 vs TSE:6869: 2.97

Sysmex FCF Margin % Historical Data

The historical data trend for Sysmex's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex FCF Margin % Chart

Sysmex Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

8.84

10.19

7.34

6.41

2.97

Sysmex Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															14.14	1.33	6.13	-5.60	8.62

Competitive Comparison of Sysmex's FCF Margin %

For the Medical Instruments & Supplies subindustry, Sysmex's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sysmex's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Sysmex's FCF Margin % falls into.

Sysmex FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Sysmex's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	13714	/	461510
	=	2.97 %

Sysmex's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	11632	/	134985
	=	8.62 %

Sysmex FCF Margin % Related Terms

Thank you for viewing the detailed overview of Sysmex's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sysmex (TSE:6869) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

SSMXY:USA SSMXF:USA 0YX:Germany

Address

1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073

Website

http://www.sysmex.co.jp

Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines